RHEI names Dr Geert Cauwenbergh CEO
This article was originally published in Scrip
Executive Summary
RHEI Pharmaceuticals (US) has appointed Dr Geert Cauwenbergh chief executive officer. He succeeds Joos Horsten, who died recently. In February, Dr Cauwenbergh founded Phases123, a company focused on identifying healthcare technology platforms and emerging healthcare companies. In 2001, he founded Barrier Therapeutics.